Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (61-70 of 435) with videos related to

Pageof 44
Sort By:
The Journal of Rheumatology|August 13, 2009
OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trialsPeter Tugwell, Maarten Boers, Vibeke Strand, et al.
Arthritis Care & Research|March 21, 2017
Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus ErythematosusStephanie G Nantes, Vibeke Strand, Jiandong Su, et al.
The Journal of Rheumatology|April 17, 2013
Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled studyVibeke Strand, Georg Schett, Chiachi Hu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2019
ReplyAlfred H J Kim, Vibeke Strand, John P Atkinson
Advances in Therapy|October 16, 2013
A phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental painClarence L Young, Vibeke Strand, Roy Altman, et al.
American Journal of Therapeutics|July 22, 2004
Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritisWilliam B White, Vibeke Strand, Richard Roberts, et al.
Current Opinion in Rheumatology|January 25, 2017
From mechanism to therapies in systemic lupus erythematosusMichael A Paley, Vibeke Strand, Alfred H J Kim
Health and Quality of Life Outcomes|March 7, 2014
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholdsVibeke Strand, Mark Kosinski, Ari Gnanasakthy, et al.
Rheumatology (Oxford, England)|July 14, 2021
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Drug Safety|June 13, 2021
Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019Juliana Setyawan, Nassir Azimi, Vibeke Strand, et al.
Pageof 44

Showing results (61-70 of 435) with videos related to

Sort By:
Pageof 44
The Journal of Rheumatology|August 13, 2009
OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trialsPeter Tugwell, Maarten Boers, Vibeke Strand, et al.
Arthritis Care & Research|March 21, 2017
Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus ErythematosusStephanie G Nantes, Vibeke Strand, Jiandong Su, et al.
The Journal of Rheumatology|April 17, 2013
Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled studyVibeke Strand, Georg Schett, Chiachi Hu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2019
ReplyAlfred H J Kim, Vibeke Strand, John P Atkinson
Advances in Therapy|October 16, 2013
A phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental painClarence L Young, Vibeke Strand, Roy Altman, et al.
American Journal of Therapeutics|July 22, 2004
Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritisWilliam B White, Vibeke Strand, Richard Roberts, et al.
Current Opinion in Rheumatology|January 25, 2017
From mechanism to therapies in systemic lupus erythematosusMichael A Paley, Vibeke Strand, Alfred H J Kim
Health and Quality of Life Outcomes|March 7, 2014
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholdsVibeke Strand, Mark Kosinski, Ari Gnanasakthy, et al.
Rheumatology (Oxford, England)|July 14, 2021
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Drug Safety|June 13, 2021
Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019Juliana Setyawan, Nassir Azimi, Vibeke Strand, et al.
Pageof 44